BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170-8. [DOI: 10.1053/gast.2001.21193] [Cited by in Crossref: 316] [Cited by in F6Publishing: 297] [Article Influence: 15.8] [Reference Citation Analysis]
Number Citing Articles
1 Sanyal A, Younossi ZM, Bass NM, Mullen KD, Poordad F, Brown RS, Vemuru RP, Mazen Jamal M, Huang S, Merchant K, Bortey E, Forbes WP. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2011;34:853-861. [PMID: 21848797 DOI: 10.1111/j.1365-2036.2011.04808.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 9.1] [Reference Citation Analysis]
2 Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615 [PMID: 18595126 DOI: 10.3748/wjg.14.3609] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 87] [Article Influence: 7.5] [Reference Citation Analysis]
3 Rojas-Loureiro G, Servín-Caamaño A, Pérez-Reyes E, Servín-Abad L, Higuera-de la Tijera F. Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study. World J Hepatol 2017; 9(5): 263-269 [PMID: 28261383 DOI: 10.4254/wjh.v9.i5.263] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986-1993. [PMID: 12190165 DOI: 10.1111/j.1572-0241.2002.05843.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 152] [Article Influence: 9.1] [Reference Citation Analysis]
5 Bajaj JS, Thacker LR, Wade JB, Sanyal AJ, Heuman DM, Sterling RK, Gibson DP, Stravitz RT, Puri P, Fuchs M. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123-1132. [PMID: 21929591 DOI: 10.1111/j.1365-2036.2011.04842.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
6 Ando Y, Ishigami M, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Fujishiro M. Sarcopenia impairs health-related quality of life in cirrhotic patients. Eur J Gastroenterol Hepatol 2019;31:1550-6. [PMID: 31206408 DOI: 10.1097/MEG.0000000000001472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Les I, Doval E, García-martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J. Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study. American Journal of Gastroenterology 2011;106:1081-8. [DOI: 10.1038/ajg.2011.9] [Cited by in Crossref: 106] [Cited by in F6Publishing: 84] [Article Influence: 10.6] [Reference Citation Analysis]
8 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 11.1] [Reference Citation Analysis]
9 Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R; Italian BCAA Study Group. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124:1792-1801. [PMID: 12806613 DOI: 10.1016/s0016-5085(03)00323-8] [Cited by in Crossref: 398] [Cited by in F6Publishing: 105] [Article Influence: 22.1] [Reference Citation Analysis]
10 Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Metab Brain Dis. 2017;32:595-605. [PMID: 28070704 DOI: 10.1007/s11011-016-9944-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
11 McSweeney L, Breckons M, Fattakhova G, Oluboyede Y, Vale L, Ternent L, Balp MM, Doward L, Brass CA, Beyer F, Sanyal A, Anstee QM. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis. JHEP Rep 2020;2:100099. [PMID: 32435754 DOI: 10.1016/j.jhepr.2020.100099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
12 Gao F, Gao R, Li G, Shang ZM, Hao JY. Health-related quality of life and survival in Chinese patients with chronic liver disease. Health Qual Life Outcomes 2013;11:131. [PMID: 23902894 DOI: 10.1186/1477-7525-11-131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
13 Zhang X, Xi W, Liu L, Wang L. Improvement in Quality of Life and Activities of Daily Living in Patients with Liver Cirrhosis with the Use of Health Education and Patient Health Empowerment. Med Sci Monit 2019;25:4602-8. [PMID: 31223134 DOI: 10.12659/MSM.914487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jindal A, Jagdish RK. Sarcopenia: Ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol. 2019;. [PMID: 31006226 DOI: 10.3350/cmh.2019.0015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
15 Yao CK, Fung J, Chu NHS, Tan VPY. Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018;52:663-673. [PMID: 29912757 DOI: 10.1097/mcg.0000000000001071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24-36. [PMID: 30345878 DOI: 10.1177/0269216318807051] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
17 Palmieri VO, Santovito D, Margari F, Lozupone M, Minerva F, Di Gennaro C, Todarello O, Palasciano G. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis. Clin Exp Med. 2015;15:65-72. [PMID: 24323278 DOI: 10.1007/s10238-013-0267-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jover R, Compañy L, Gutiérrez A, Lorente M, Zapater P, Poveda MJ, Such J, Pascual S, Palazón JM, Carnicer F, Ferrandis F, Pérez-mateo M. Clinical significance of extrapyramidal signs in patients with cirrhosis. Journal of Hepatology 2005;42:659-65. [DOI: 10.1016/j.jhep.2004.12.030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
19 Amodio P. Health related quality of life and minimal hepatic encephalopathy. It is time to insert ‘quality’ in health care. Journal of Gastroenterology and Hepatology 2009;24:329-30. [DOI: 10.1111/j.1440-1746.2009.05781.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
20 Jepsen P, Younossi ZM. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. J Hepatol 2021;75 Suppl 1:S3-S13. [PMID: 34039490 DOI: 10.1016/j.jhep.2020.11.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol. 2016;31:1203-1209. [PMID: 26716736 DOI: 10.1111/jgh.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
22 Castera L, Constant A, Bernard PH, de Ledinghen V, Couzigou P. Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C. J Viral Hepat. 2006;13:482-488. [PMID: 16792542 DOI: 10.1111/j.1365-2893.2005.00719.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
23 Estraviz B, Quintana JM, Valdivieso A, Bilbao A, Padierna A, de Urbina JO, Sarabia S. Factors influencing change in health-related quality of life after liver transplantation. Clin Transplant 2007;21:481-99. [PMID: 17645707 DOI: 10.1111/j.1399-0012.2007.00672.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
24 Shabanloei R, Ebrahimi H, Ahmadi F, Mohammadi E, Dolatkhah R. Despair of Treatment: A Qualitative Study of Cirrhotic Patientsʼ Perception of Treatment. Gastroenterology Nursing 2017;40:26-37. [DOI: 10.1097/sga.0000000000000162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bersagliere A, Raduazzo ID, Nardi M, Schiff S, Gatta A, Amodio P, Achermann P, Montagnese S. Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. Hepatology 2012;55:869-78. [PMID: 21994139 DOI: 10.1002/hep.24741] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
26 Makhlouf NA, Mahran ZG, Sadek SH, Magdy DM, Makhlouf HA. Six-minute walk test before and after large-volume paracentesis in cirrhotic patients with refractory ascites: A pilot study. Arab J Gastroenterol 2019;20:81-5. [PMID: 31182343 DOI: 10.1016/j.ajg.2019.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Abd-Elsalam S, Arafa M, Elkadeem M, Elfert A, Soliman S, Elkhalawany W, Badawi R. Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients. Eur J Gastroenterol Hepatol 2019;31:499-502. [PMID: 30444744 DOI: 10.1097/MEG.0000000000001310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, Gerber L, Younossi ZM. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26:815-820. [PMID: 17767465 DOI: 10.1111/j.1365-2036.2007.03426.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 4.9] [Reference Citation Analysis]
29 Comparato G, Fanigliulo L, Aragona G, Cavestro GM, Cavallaro LG, Leandro G, Pilotto A, Nervi G, Soliani P, Sianesi M, Franzé A, Di Mario F. Quality of Life in Uncomplicated Symptomatic Diverticular Disease: Is It Another Good Reason for Treatment? Dig Dis 2007;25:252-9. [DOI: 10.1159/000103896] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
30 Frith J, Newton JL. Autonomic dysfunction in chronic liver disease. Hepat Med. 2011;3:81-87. [PMID: 24367224 DOI: 10.2147/hmer.s16312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
31 Macken L, Joshi D, Messenger J, Austin M, Tibble J, Mason L, Verma S. Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: A case series. Palliat Med 2017;31:671-5. [PMID: 27707955 DOI: 10.1177/0269216316671281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
32 Silva LD, Cunha CC, Cunha LR, Araújo RF, Barcelos VM, Menta PL, Neves FS, Teixeira R, Rocha GA, Gontijo ED. Depression rather than liver impairment reduces quality of life in patients with hepatitis C. Braz J Psychiatry 2015;37:21-30. [PMID: 25806552 DOI: 10.1590/1516-4446-2014-1446] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
33 Stine JG, Stukenborg GJ, Wang J, Adkins A, Niccum B, Zimmet A, Argo CK. Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing. Ann Hepatol 2020;19:62-8. [PMID: 31558420 DOI: 10.1016/j.aohep.2019.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
34 Mcnally B, Carey E. Objective Versus Subjective Assessment of Functional Status in Candidates for Liver Transplantation. Transplantation Proceedings 2018;50:3508-12. [DOI: 10.1016/j.transproceed.2018.06.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Volk ML, Burne R, Guérin A, Shi S, Joseph GJ, Heimanson Z, Ahmad M. Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States. J Med Econ 2021;24:202-11. [PMID: 33464935 DOI: 10.1080/13696998.2021.1877148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Kimer N, Riedel AN, Hobolth L, Mortensen C, Madsen LG, Andersen ML, Schiødt FV, Møller S, Gluud LL. Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series. Medicina (Kaunas) 2020;56:E565. [PMID: 33121063 DOI: 10.3390/medicina56110565] [Reference Citation Analysis]
37 Kalaitzakis E, Benito de Valle M, Rahman M, Lindkvist B, Björnsson E, Chapman R, Kontodimopoulos N. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis. Qual Life Res 2016;25:947-57. [PMID: 26471264 DOI: 10.1007/s11136-015-1161-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
38 Lemyze M, Dharancy S, Wallaert B. Response to exercise in patients with liver cirrhosis: implications for liver transplantation. Dig Liver Dis. 2013;45:362-366. [PMID: 23137795 DOI: 10.1016/j.dld.2012.09.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
39 Younossi Z, Henry L. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology. 2016;150:1778-1785. [PMID: 26980624 DOI: 10.1053/j.gastro.2016.03.005] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 28.2] [Reference Citation Analysis]
40 Gotthardt DN, Rupp C, Bruhin M, Schellberg D, Weiss KH, Stefan R, Donnerstag N, Stremmel W, Löwe B, Juenger J. Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2014;26:1374-1379. [PMID: 25341059 DOI: 10.1097/meg.0000000000000223] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
41 Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is "normal"? J Hepatol 2017;66:825-35. [PMID: 27923694 DOI: 10.1016/j.jhep.2016.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol. 2014;12:692-698. [PMID: 23978345 DOI: 10.1016/j.cgh.2013.08.027] [Cited by in Crossref: 127] [Cited by in F6Publishing: 103] [Article Influence: 15.9] [Reference Citation Analysis]
43 Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629-635. [PMID: 19302444 DOI: 10.1111/j.1478-3231.2009.02009.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 12.5] [Reference Citation Analysis]
44 Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl. 2005;11:218-223. [PMID: 15666392 DOI: 10.1002/lt.20345] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
45 Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY, So TM. Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes. 2009;7:52. [PMID: 19500349 DOI: 10.1186/1477-7525-7-52] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
46 Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of Minimal Hepatic Encephalopathy. Metab Brain Dis 2004;19:253-67. [DOI: 10.1023/b:mebr.0000043975.01841.de] [Cited by in Crossref: 196] [Cited by in F6Publishing: 76] [Article Influence: 11.5] [Reference Citation Analysis]
47 Benito de Valle M, Rahman M, Lindkvist B, Björnsson E, Chapman R, Kalaitzakis E. Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2012;10:769-775.e2. [DOI: 10.1016/j.cgh.2012.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
48 Cox-north P, Doorenbos A, Shannon SE, Scott J, Curtis JR. The Transition to End-of-Life Care in End-Stage Liver Disease: . Journal of Hospice & Palliative Nursing 2013;15:209-15. [DOI: 10.1097/njh.0b013e318289f4b0] [Cited by in Crossref: 21] [Article Influence: 2.6] [Reference Citation Analysis]
49 Ong JP, Oehler G, Krüger-jansen C, Lambert-baumann J, Younossi ZM. Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy: An Open-Label, Prospective, Multicentre Observational Study. Clinical Drug Investigation 2011;31:213-20. [DOI: 10.2165/11586700-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
50 Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep 2013;15:301. [PMID: 23250701 DOI: 10.1007/s11894-012-0301-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
51 Patidar KR, Thacker LR, Wade JB, White MB, Gavis EA, Fagan A, Sterling RK, Fuchs M, Siddiqui MS, Matherly S, Stravitz RT, Sanyal AJ, Puri P, Luketic VA, Bajaj JS. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci 2017;62:1173-9. [PMID: 28258378 DOI: 10.1007/s10620-017-4509-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
52 Sutphin PD, Lamus D, Kalva SP, Li J, Corbin IR. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began to Where We Are Going. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 169-94. [DOI: 10.1007/978-3-030-21540-8_9] [Reference Citation Analysis]
53 Román E, Nieto JC, Gely C, Vidal S, Pozuelo M, Poca M, Juárez C, Guarner C, Manichanh C, Soriano G. Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial. Hepatol Commun 2019;3:632-45. [PMID: 31061952 DOI: 10.1002/hep4.1325] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
54 Pai R, Karvellas CJ. Is palliative care appropriate in the liver transplant candidate? Clin Liver Dis (Hoboken) 2015;6:24-6. [PMID: 31040980 DOI: 10.1002/cld.482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Solbach P, Höner zu Siederdissen C, Wellhöner F, Richter N, Heidrich B, Lenzen H, Kerstin P, Hueper K, Manns MP, Wedemeyer H, Jaeckel E. Automated low-flow ascites pump in a real-world setting: complications and outcomes. European Journal of Gastroenterology & Hepatology 2018;30:1082-9. [DOI: 10.1097/meg.0000000000001149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
56 Macken L, Mason L, Evans C, Gage H, Jordan J, Austin M, Parnell N, Cooper M, Steer S, Boles J, Bremner S, Lambert D, Crook D, Earl G, Timeyin J, Verma S. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial. Trials 2018;19:401. [PMID: 30053891 DOI: 10.1186/s13063-018-2779-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Iadevaia MD, Prete AD, Cesaro C, Gaeta L, Zulli C, Loguercio C. Rifaximin in the treatment of hepatic encephalopathy. Hepat Med. 2011;3:109-117. [PMID: 24367227 DOI: 10.2147/hmer.s11988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Bianchi G, Loguercio C, Sgarbi D, Abbiati R, Brunetti N, De Simone T, Zoli M, Marchesini G. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis. 2003;35:46-54. [PMID: 12725608 DOI: 10.1016/s1590-8658(02)00011-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
59 Cerrelli F, Manini R, Forlani G, Baraldi L, Melchionda N, Marchesini G. Eating behavior affects quality of life in type 2 diabetes mellitus. Eat Weight Disord 2005;10:251-7. [PMID: 16755169 DOI: 10.1007/BF03327492] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
60 Gao R, Gao F, Li G, Hao JY. Health-related quality of life in chinese patients with chronic liver disease. Gastroenterol Res Pract. 2012;2012:516140. [PMID: 22701477 DOI: 10.1155/2012/516140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
61 Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol. 2008;103:1413-1420. [PMID: 18510613 DOI: 10.1111/j.1572-0241.2008.01788.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
62 Golfieri L, Gitto S, Morelli MC, Pinna AD, Grandi S, Andreone P. Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view. Expert Rev Anti Infect Ther 2017;15:759-65. [PMID: 28756716 DOI: 10.1080/14787210.2017.1362334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015;29:134-141. [PMID: 25430554 DOI: 10.1111/ctr.12493] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 12.7] [Reference Citation Analysis]
64 Martin LM, Dan AA, Younossi ZM. Measurement of health-related quality of life in patients with chronic liver disease. Liver Transpl 2006;12:22-3. [DOI: 10.1002/lt.20575] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
65 Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes. 2005;3:35. [PMID: 15904528 DOI: 10.1186/1477-7525-3-35] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
66 Nokhodian Z, Ataei B, Kassaian N, Adibi P, Farajzadegan Z. Assessment of quality of life in hepatitis B patients in Iran. Indian J Gastroenterol 2009;28:116-7. [PMID: 19907965 DOI: 10.1007/s12664-009-0041-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Parkash O, Jafri W, Munir SM, Iqbal R. Assessment of malnutrition in patients with liver cirrhosis using protein calorie malnutrition (PCM) score verses bio-electrical impedance analysis (BIA). BMC Res Notes. 2018;11:545. [PMID: 30068390 DOI: 10.1186/s13104-018-3640-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
68 Darwish Murad S, Heimbach JK, Gores GJ, Rosen CB, Benson JT, Kim WR. Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl 2013;19:521-8. [PMID: 23447435 DOI: 10.1002/lt.23630] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
69 Córdoba J. Quality of life in chronic liver diseases and in hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 442-57. [DOI: 10.1007/1-4020-4456-9_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016;43:765-777. [PMID: 26847265 DOI: 10.1111/apt.13549] [Cited by in Crossref: 155] [Cited by in F6Publishing: 143] [Article Influence: 31.0] [Reference Citation Analysis]
71 van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. Generic and disease-specific health related quality of life of liver patients with various aetiologies: A survey. Qual Life Res 2007;16:375-88. [DOI: 10.1007/s11136-006-9131-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
72 Lee MK, Chung WJ. Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study. Health Qual Life Outcomes 2021;19:148. [PMID: 34001156 DOI: 10.1186/s12955-021-01787-9] [Reference Citation Analysis]
73 Kaplan A, Fortune B, Ufere N, Brown RS, Rosenblatt R. National Trends in Location of Death in Patients With End‐Stage Liver Disease. Liver Transpl 2021;27:165-76. [DOI: 10.1002/lt.25952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
74 Jang ES, Hwang SH, Kim JW, Jeong SH. Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study. Yonsei Med J 2021;62:21-8. [PMID: 33381931 DOI: 10.3349/ymj.2021.62.1.21] [Reference Citation Analysis]
75 Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ. Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol 2016;4:281-7. [PMID: 28097095 DOI: 10.14218/JCTH.2016.00049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
76 Solà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, Pavesi M, Arroyo V, Guevara M, Ginès P. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57:1199-1206. [PMID: 22824819 DOI: 10.1016/j.jhep.2012.07.020] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 8.7] [Reference Citation Analysis]
77 Younossi ZM. Chronic liver disease and health-related quality of life. Gastroenterology 2001;120:305-7. [DOI: 10.1053/gast.2001.22073] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
78 Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, Matheny ME. Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis. Dig Dis Sci 2020;65:1003-31. [PMID: 31531817 DOI: 10.1007/s10620-019-05826-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
79 Amodio P, Salari L, Montagnese S, Schiff S, Neri D, Bianco T, Minazzato L. Hepatitis C virus infection and health-related quality of life. World J Gastroenterol 2012; 18(19): 2295-2299 [PMID: 22654420 DOI: 10.3748/wjg.v18.i19.2295] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
80 Nouri-Vaskeh M, Afshan H, Malek Mahdavi A, Alizadeh L, Fan X, Zarei M. Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial. Complement Ther Med 2020;49:102351. [PMID: 32147077 DOI: 10.1016/j.ctim.2020.102351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DE. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61:1158-1165. [PMID: 25010259 DOI: 10.1016/j.jhep.2014.06.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 9.7] [Reference Citation Analysis]
82 Riedel AN, Kimer N, Jensen ASH, Dahl EK, Israelsen M, Aamann L, Gluud LL. Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients. World J Gastroenterol 2018; 24(15): 1650-1657 [PMID: 29686472 DOI: 10.3748/wjg.v24.i15.1650] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Reference Citation Analysis]
84 Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL. Physical exercise for people with cirrhosis. Cochrane Database Syst Rev 2018;12:CD012678. [PMID: 30575956 DOI: 10.1002/14651858.CD012678.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
85 Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Moscucci F, Merli M, Mina C, Marianetti M, Fratino M, Izzo C, Merkel C, Riggio O. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients. Metab Brain Dis. 2013;28:239-243. [PMID: 23296469 DOI: 10.1007/s11011-012-9364-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
86 Poupon RE, Chrétien Y, Chazouillères O, Poupon R, Chwalow J. Quality of life in patients with primary biliary cirrhosis. Hepatology. 2004;40:489-494. [PMID: 15368455 DOI: 10.1002/hep.20276] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 5.3] [Reference Citation Analysis]
87 Parikh-Patel A, Gold EB, Utts J, Worman H, Krivy KE, Gershwin ME. Functional status of patients with primary biliary cirrhosis. Am J Gastroenterol 2002;97:2871-9. [PMID: 12425562 DOI: 10.1111/j.1572-0241.2002.07055.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
88 Abd-Elsalam S, Ebrahim S, Soliman S, Alkhalawany W, Elfert A, Hawash N, Elkadeem M, Badawi R. Orphenadrine in treatment of muscle cramps in cirrhotic patients: a randomized study. Eur J Gastroenterol Hepatol 2020;32:1042-5. [PMID: 31834056 DOI: 10.1097/MEG.0000000000001622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
89 Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199-2205. [PMID: 11467653 DOI: 10.1111/j.1572-0241.2001.03956.x] [Cited by in Crossref: 198] [Cited by in F6Publishing: 197] [Article Influence: 9.9] [Reference Citation Analysis]
90 European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-417. [PMID: 20633946 DOI: 10.1016/j.jhep.2010.05.004] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 829] [Article Influence: 91.1] [Reference Citation Analysis]
91 Duan Z, Kong Y, Zhang J, Guo H. Psychological comorbidities in Chinese patients with acute-on-chronic liver failure. General Hospital Psychiatry 2012;34:276-81. [DOI: 10.1016/j.genhosppsych.2011.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
92 Björnsson E, Verbaan H, Oksanen A, Frydén A, Johansson J, Friberg S, Dalgård O, Kalaitzakis E. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scand J Gastroenterol. 2009;44:878-887. [PMID: 19437190 DOI: 10.1080/00365520902898135] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
93 Juanbeltz R, Martínez-Baz I, San Miguel R, Goñi-Esarte S, Cabasés JM, Castilla J. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients. PLoS One 2018;13:e0205277. [PMID: 30300395 DOI: 10.1371/journal.pone.0205277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
94 Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54:1063-1070. [PMID: 21563202 DOI: 10.1002/hep.24412] [Cited by in Crossref: 191] [Cited by in F6Publishing: 173] [Article Influence: 19.1] [Reference Citation Analysis]
95 Fagerström C, Frisman GH. Living With Liver Cirrhosis: A Vulnerable Life. Gastroenterology Nursing 2017;40:38-46. [DOI: 10.1097/sga.0000000000000158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
96 Sargent S, Wainwright SP. Quality of life following emergency liver transplantation for acute liver failure. Nurs Crit Care. 2006;11:168-176. [PMID: 16869523 DOI: 10.1111/j.1362-1017.2006.00169.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
97 Nakanishi H, Kurosaki M, Nakanishi K, Tsuchiya K, Noda T, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Itakura J, Anami K, Asahina Y, Enomoto N, Higuchi T, Izumi N. Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res 2014;44:319-26. [PMID: 23607661 DOI: 10.1111/hepr.12127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
98 Córdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004;39:599-601. [DOI: 10.1002/hep.20120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
99 Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357-366. [PMID: 11826409 DOI: 10.1053/jhep.2002.30957] [Cited by in Crossref: 279] [Cited by in F6Publishing: 235] [Article Influence: 14.7] [Reference Citation Analysis]
100 Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, Kaito M, Takeda K, Adachi Y. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 2005; 11(43): 6792-6799 [PMID: 16425386 DOI: 10.3748/wjg.v11.i43.6792] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
101 Thiele M, Askgaard G, Timm HB, Hamberg O, Gluud LL. Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepat Res Treat 2013;2013:479639. [PMID: 24490061 DOI: 10.1155/2013/479639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
102 Kimbell B, Murray SA. What is the patient experience in advanced liver disease? A scoping review of the literature. BMJ Support Palliat Care 2015;5:471-80. [DOI: 10.1136/bmjspcare-2012-000435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
103 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009;29:1365-1371. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
104 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
105 Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. Dig Dis Sci 2013;58:2976-85. [PMID: 23512406 DOI: 10.1007/s10620-013-2638-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
106 Freeman RB. MELD and the quality of life. Liver Transpl 2005;11:134-6. [DOI: 10.1002/lt.20322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
107 Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation. J Pain Symptom Manage. 2015;50:882-6.e2. [PMID: 26303186 DOI: 10.1016/j.jpainsymman.2015.07.014] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 11.7] [Reference Citation Analysis]
108 Martin LM, Sheridan MJ, Younossi ZM. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep. 2002;4:79-83. [PMID: 11825545 DOI: 10.1007/s11894-002-0041-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
109 Janani K, Varghese J, Jain M, Harika K, Srinivasan V, Michael T, Jayanthi V. HRQOL using SF36 (generic specific) in liver cirrhosis. Indian J Gastroenterol 2017;36:313-7. [DOI: 10.1007/s12664-017-0773-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
110 Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int. 2010;30:574-582. [PMID: 20456040 DOI: 10.1111/j.1478-3231.2010.02213.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
111 Rocca P. Predictors of psychiatric disorders in liver transplantation candidates: Logistic regression models. Liver Transplantation 2003;9:721-6. [DOI: 10.1053/jlts.2003.50133] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
112 Kondo Y, Yoshida H, Tateishi R, Shiina S, Mine N, Yamashiki N, Sato S, Kato N, Kanai F, Yanase M. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:197-203. [PMID: 17295871 DOI: 10.1111/j.1440-1746.2006.04456.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
113 Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559. [PMID: 17326150 DOI: 10.1002/hep.21533] [Cited by in Crossref: 385] [Cited by in F6Publishing: 325] [Article Influence: 27.5] [Reference Citation Analysis]
114 Kalaitzakis E, Simrén M, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Björnsson E. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol 2006;41:1464-72. [PMID: 17101578 DOI: 10.1080/00365520600825117] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 5.6] [Reference Citation Analysis]
115 Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res. 2014;44:149-158. [PMID: 23819582 DOI: 10.1111/hepr.12194] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
116 Wehler M, Geise A, Hadzionerovic D, Aljukic E, Reulbach U, Hahn EG, Strauss R. Health-related quality of life of patients with multiple organ dysfunction: Individual changes and comparison with normative population: . Critical Care Medicine 2003;31:1094-101. [DOI: 10.1097/01.ccm.0000059642.97686.8b] [Cited by in Crossref: 75] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
117 Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease. Am J Gastroenterol. 2004;99:1726-1732. [PMID: 15330910 DOI: 10.1111/j.1572-0241.2004.30300.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
118 Marchesini G, Marzocchi R, Noia M, Bianchi G. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 2005;135:1596S-601S. [PMID: 15930476 DOI: 10.1093/jn/135.6.1596S] [Cited by in Crossref: 52] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
119 Pratap Mouli V, Benjamin J, Bhushan Singh M, Mani K, Garg SK, Saraya A, Joshi YK. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol Res. 2015;45:880-889. [PMID: 25266207 DOI: 10.1111/hepr.12429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
120 Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 2018; 24(48): 5446-5453 [PMID: 30622374 DOI: 10.3748/wjg.v24.i48.5446] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
121 Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12(21): 3380-3385 [PMID: 16733855 DOI: 10.3748/wjg.v12.i21.3385] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
122 Youssef NF, Shepherd A, Evans JM, Wyke S. Translating and testing the Liver Disease Symptom Index 2.0 for administration to people with liver cirrhosis in Egypt. Int J Nurs Pract. 2012;18:406-416. [PMID: 22845641 DOI: 10.1111/j.1440-172X.2012.02048.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Lindqvist C, Slinde F, Majeed A, Bottai M, Wahlin S. Nutrition impact symptoms are related to malnutrition and quality of life – A cross-sectional study of patients with chronic liver disease. Clinical Nutrition 2020;39:1840-8. [DOI: 10.1016/j.clnu.2019.07.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
124 Hudson B, Hunt V, Waylen A, Mccune CA, Verne J, Forbes K. The incompatibility of healthcare services and end-of-life needs in advanced liver disease: A qualitative interview study of patients and bereaved carers. Palliat Med 2018;32:908-18. [DOI: 10.1177/0269216318756222] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
125 Mikkelsen MR, Hendriksen C, Schiødt FV, Rydahl-hansen S. Alcoholic liver disease patients’ perspective of a coping and physical activity-oriented rehabilitation intervention after hepatic encephalopathy. J Clin Nurs 2016;25:2457-67. [DOI: 10.1111/jocn.13265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Barboza KC, Salinas LM, Sahebjam F, Jesudian AB, Weisberg IL, Sigal SH. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients. Metab Brain Dis 2016;31:869-80. [DOI: 10.1007/s11011-016-9817-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
127 Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: A review. Liver Int 2018;38:768-75. [PMID: 29112338 DOI: 10.1111/liv.13620] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
128 Kanwal F, Volk M, Singal A, Angeli P, Talwalkar J. Improving quality of health care for patients with cirrhosis. Gastroenterology. 2014;147:1204-1207. [PMID: 25449026 DOI: 10.1053/j.gastro.2014.10.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
129 Mikkelsen MR, Hendriksen C, Schiødt FV, Rydahl-hansen S. Coping and rehabilitation in alcoholic liver disease patients after hepatic encephalopathy - in interaction with professionals and relatives. J Clin Nurs 2015;24:3627-37. [DOI: 10.1111/jocn.13006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
130 Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: Translation and validation in Thais. World J Gastroenterol 2004; 10(13): 1954-1957 [PMID: 15222044 DOI: 10.3748/wjg.v10.i13.1954] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
131 Pradhan RR, Kafle Bhandari B, Pathak R, Poudyal S, Anees S, Sharma S, Khadga P. The Assessment of Health-Related Quality of Life in Patients With Chronic Liver Disease: A Single-Center Study. Cureus 2020;12:e10727. [PMID: 33145133 DOI: 10.7759/cureus.10727] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 De Rui M, Middleton B, Sticca A, Gatta A, Amodio P, Skene DJ, Montagnese S. Sleep and circadian rhythms in hospitalized patients with decompensated cirrhosis: effect of light therapy. Neurochem Res 2015;40:284-92. [PMID: 25135598 DOI: 10.1007/s11064-014-1414-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
133 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
134 van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterol. 2003;3:33. [PMID: 14617381 DOI: 10.1186/1471-230X-3-33] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
135 Ohlendorf V, Schäfer A, Christensen S, Heyne R, Naumann U, Link R, Herold C, Schiffelholz W, Günther R, Cornberg M, Serfert Y, Maasoumy B, Wedemeyer H, Kraus MR. Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R). J Viral Hepat 2021;28:1206-18. [PMID: 34003549 DOI: 10.1111/jvh.13546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, Bolus R, Kim SJ, Gralnek IM. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther 2008;28:1088-101. [PMID: 18671776 DOI: 10.1111/j.1365-2036.2008.03817.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
137 Fan SY, Eiser C, Ho MC. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol. 2010;8:559-64.e1-10. [PMID: 20304101 DOI: 10.1016/j.cgh.2010.03.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
138 Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017;46:16-25. [PMID: 28464346 DOI: 10.1111/apt.14078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
139 Camarata MA, Ala A, Coskun AK, Deng Y, Gonzalez-Peralta RP, Maciejewski KR, Patel A, Rubman S, To U, Tomlin R, Schilsky ML, Zimbrean PC. The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease. J Acad Consult Liaison Psychiatry 2021;62:528-37. [PMID: 34044196 DOI: 10.1016/j.jaclp.2021.04.004] [Reference Citation Analysis]
140 Ufere NN, O'Riordan DL, Bischoff KE, Marks AK, Eneanya N, Chung RT, Jackson V, Pantilat SZ, El-Jawahri A. Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease. J Pain Symptom Manage 2019;58:766-73. [PMID: 31326503 DOI: 10.1016/j.jpainsymman.2019.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
141 Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2013;28:1187-1193. [PMID: 23425082 DOI: 10.1111/jgh.12160] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
142 Bravata DM, Keeffe EB. Quality of life and employment after liver transplantation. Liver Transpl. 2001;7:S119-S123. [PMID: 11689784 DOI: 10.1053/jlts.2001.28520] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
143 Chatrath H, Liangpunsakul S, Ghabril M, Otte J, Chalasani N, Vuppalanchi R. Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med. 2012;125:1019-1025. [PMID: 22835465 DOI: 10.1016/j.amjmed.2012.03.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
144 Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012;5:446. [PMID: 22905795 DOI: 10.1186/1556-0500.5.446] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Fukushima H, Miwa Y, Shiraki M, Gomi I, Toda K, Kuriyama S, Nakamura H, Wakahara T, Era S, Moriwaki H. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatology Research 2007;37:765-70. [DOI: 10.1111/j.1872-034x.2007.00123.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
146 Alt Y, Grimm A, Schlegel L, Grambihler A, Kittner JM, Wiltink J, Galle PR, Wörns MA, Schattenberg JM. The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease. PLoS One 2016;11:e0151200. [PMID: 26990427 DOI: 10.1371/journal.pone.0151200] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
147 Urano E, Yamanaka-okumura H, Teramoto A, Sugihara K, Morine Y, Imura S, Utsunomiya T, Shimada M, Takeda E. Pre- and postoperative nutritional assessment and health-related quality of life in recipients of living donor liver transplantation: Nutritional assessment and HRQOL in LDLT. Hepatol Res 2014;44:1102-9. [DOI: 10.1111/hepr.12263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
148 Yadav SK, Saksena S, Srivastava A, Srivastava A, Saraswat VA, Thomas MA, Rathore RK, Gupta RK. Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood. AJNR Am J Neuroradiol 2010;31:1337-42. [PMID: 20223885 DOI: 10.3174/ajnr.A2045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
149 Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12(21): 3380-3385 [DOI: 10.3748/wjg.v12.i21.3380] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
150 Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome? Metab Brain Dis 2009;24:427-39. [PMID: 19756996 DOI: 10.1007/s11011-009-9146-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
151 Sumskiene J, Sumskas L, Petrauskas D, Kupcinskas L. Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania. World J Gastroenterol 2006; 12(48): 7792-7797 [PMID: 17203522 DOI: 10.3748/wjg.v12.i48.7792] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
152 Nagel M, Labenz C, Wörns MA, Marquardt JU, Galle PR, Schattenberg JM, Nguyen-Tat M. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives. Health Qual Life Outcomes 2020;18:10. [PMID: 31931822 DOI: 10.1186/s12955-019-1268-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Elfert AA, Abo Ali L, Soliman S, Zakaria S, Shehab El-din I, Elkhalawany W, Abd-elsalam S. Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosis: . European Journal of Gastroenterology & Hepatology 2016;28:1280-4. [DOI: 10.1097/meg.0000000000000714] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
154 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
155 Vidot H, Cvejic E, Carey S, Strasser SI, McCaughan GW, Allman-Farinelli M, Shackel NA. Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. Aliment Pharmacol Ther 2018;48:704-12. [PMID: 30136291 DOI: 10.1111/apt.14950] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
156 Tsai C, Chu C, Wang Y, Liu P, Huang Y, Lin H, Lee F, Lu C. Increased serum interleukin-6, not minimal hepatic encephalopathy, predicts poor sleep quality in nonalcoholic cirrhotic patients. Aliment Pharmacol Ther 2016;44:836-45. [DOI: 10.1111/apt.13765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
157 Serigado JM, Barboza KC, Marcus P, Sigal SH. Clinical Impact of Depression in Cirrhosis. Curr Hepatology Rep 2018;17:22-32. [DOI: 10.1007/s11901-018-0386-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
158 Lauridsen MM, Frøjk J, de Muckadell OB, Vilstrup H. Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons. Metab Brain Dis 2014;29:655-60. [PMID: 25008562 DOI: 10.1007/s11011-014-9583-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
159 Woodland H, Hudson B, Forbes K, McCune A, Wright M; British Association for the Study of the Liver (BASL) End of Life Special Interest Group. Palliative care in liver disease: what does good look like? Frontline Gastroenterol 2020;11:218-27. [PMID: 32419913 DOI: 10.1136/flgastro-2019-101180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
160 Macdonald S, Jalan R. Editorial: alfapump-an alternative to large-volume paracentesis for patients with refractory ascites? Aliment Pharmacol Ther 2018;47:139-40. [DOI: 10.1111/apt.14390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, Chawla Y. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis 2013;28:249-59. [DOI: 10.1007/s11011-013-9393-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
162 Kronsten VT, Shawcross DL. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation? Anal Biochem 2021;:114437. [PMID: 34715068 DOI: 10.1016/j.ab.2021.114437] [Reference Citation Analysis]
163 Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622-1626. [PMID: 12924658 DOI: 10.1023/a:1024784327783] [Cited by in Crossref: 158] [Cited by in F6Publishing: 68] [Article Influence: 8.8] [Reference Citation Analysis]
164 Vieira DA, da Cunha LR, da Silva CB, Almeida MTB, Gomes AD, de Faria CLL Jr, Teixeira R, Neves FS, Rocha GA, de Melo FF, de Magalhães Queiroz DM, Silva LD. The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C. Qual Life Res 2019;28:1531-42. [PMID: 30734130 DOI: 10.1007/s11136-019-02129-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
165 Erim Y, Tagay S, Beckmann M, Bein S, Cicinnati V, Beckebaum S, Senf W, Schlaak JF. Depression and protective factors of mental health in people with hepatitis C: A questionnaire survey. International Journal of Nursing Studies 2010;47:342-9. [DOI: 10.1016/j.ijnurstu.2009.08.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
166 Janani K, Jain M, Vargese J, Srinivasan V, Harika K, Michael T, Venkataraman J. Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires. Clin Exp Hepatol 2018;4:232-9. [PMID: 30603670 DOI: 10.5114/ceh.2018.80124] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
167 Vicco MH, Rodeles L, Ferini F, Long AK, Musacchio HM. In-hospital mortality risk factors in patients with ascites due to cirrhosis. Rev Assoc Med Bras (1992) 2015;61:35-9. [PMID: 25909206 DOI: 10.1590/1806-9282.61.01.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
168 Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, Abbiati R, Zoli M. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis. 2005;37:593-600. [PMID: 15869912 DOI: 10.1016/j.dld.2005.01.020] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 6.8] [Reference Citation Analysis]
169 Kim HJ, Lee HK, Cho JH. Factor analysis of the biochemical markers related to liver cirrhosis. Pak J Med Sci 2015;31:1043-6. [PMID: 26648983 DOI: 10.12669/pjms.315.8025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
170 Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 2007;45:547-8. [DOI: 10.1002/hep.21617] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
171 Labenz C, Toenges G, Schattenberg JM, Nagel M, Huber Y, Marquardt JU, Galle PR, Wörns MA. Health-related quality of life in patients with compensated and decompensated liver cirrhosis. Eur J Intern Med 2019;70:54-9. [PMID: 31530418 DOI: 10.1016/j.ejim.2019.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
172 Mehta SS, Fallon MB. Muscle Cramps in Cirrhosis: A Moving Target. Clinical Gastroenterology and Hepatology 2015;13:1544-6. [DOI: 10.1016/j.cgh.2015.02.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
173 Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42-S48. [PMID: 26041957 DOI: 10.1016/j.jceh.2014.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
174 Kato A, Watanabe Y, Sawara K, Suzuki K. Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests). Hepatology Research 2008;38:S122-7. [DOI: 10.1111/j.1872-034x.2008.00437.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Russell RT, Feurer ID, Wisawatapnimit P, Lillie ES, Castaldo ET, Pinson CW. Profile of health-related quality of life outcomes after liver transplantation: univariate effects and multivariate models. HPB (Oxford) 2008;10:30-7. [PMID: 18695756 DOI: 10.1080/13651820701883106] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
176 Boyd K, Kimbell B, Murray S, Iredale J. Living and dying well with end-stage liver disease: time for palliative care? Hepatology 2012;55:1650-1. [PMID: 22290640 DOI: 10.1002/hep.25621] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
177 Riedel AN, Kimer N, Hobolth L, Gluud LL. Prognosis of patients with ascites after PleurX insertion: an observational study. Scand J Gastroenterol. 2018;53:340-344. [PMID: 29411667 DOI: 10.1080/00365521.2018.1436190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
178 Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, Wang JB, Jiang HX, Yang JH, Xu Y, Li X, Xu JM, Zhang G, Zhou XM, Zhuge YZ, Tian DA, Ye J, Liu YL. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19(30): 4984-4991 [PMID: 23946605 DOI: 10.3748/wjg.v19.i30.4984] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
179 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;:1-10. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Reference Citation Analysis]
180 Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L; American Association for the Study of Liver Diseases; United States Food and Drug Administration. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology. 2015;61:1392-1405. [PMID: 25557690 DOI: 10.1002/hep.27678] [Cited by in Crossref: 213] [Cited by in F6Publishing: 195] [Article Influence: 35.5] [Reference Citation Analysis]
181 Rannard A, Buck D, Jones DE, James OF, Jacoby A. Assessing quality of life in primary biliary cirrhosis. Clinical Gastroenterology and Hepatology 2004;2:164-74. [DOI: 10.1016/s1542-3565(03)00323-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
182 Mehta SS, Fallon MB. Muscle Cramps in Liver Disease. Clinical Gastroenterology and Hepatology 2013;11:1385-91. [DOI: 10.1016/j.cgh.2013.03.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
183 Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry MP. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation? Prog Transplant 2011;21:207-14. [PMID: 21977881 DOI: 10.7182/prtr.21.3.c508417x010g552n] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
184 Patel AV, Wade JB, Thacker LR, Sterling RK, Siddiqui MS, Stravitz RT, Sanyal AJ, Luketic V, Puri P, Fuchs M, Matherly S, White MB, Unser A, Heuman DM, Bajaj JS. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score. Clin Gastroenterol Hepatol 2015;13:987-91. [PMID: 25445772 DOI: 10.1016/j.cgh.2014.09.049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
185 Kok B, Whitlock R, Ferguson T, James Bailey R, Warren Burak K, Kowalczewski J, Tangri N, Tandon P. Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis. Am J Gastroenterol 2020;115:575-83. [PMID: 32079859 DOI: 10.14309/ajg.0000000000000545] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
186 Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30:469-476. [PMID: 19508612 DOI: 10.1111/j.1365-2036.2009.04061.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
187 Sirivatanauksorn Y, Dumronggittigule W, Limsrichamrern S, Iramaneerat C, Kolladarungkri T, Kositamongkol P, Mahawithitwong P, Asavakarn S, Tovikkai C. Quality of life among liver transplantation patients. Transplant Proc. 2012;44:532-538. [PMID: 22410064 DOI: 10.1016/j.transproceed.2011.12.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
188 Cron DC, Tincopa MA, Lee JS, Waljee AK, Hammoud A, Brummett CM, Waljee JF, Englesbe MJ, Sonnenday CJ. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. Transplantation 2021;105:100-7. [PMID: 32022738 DOI: 10.1097/TP.0000000000003155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
189 Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med. 2014;17:1271-1277. [PMID: 25390468 DOI: 10.1089/jpm.2013.0167] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
190 Patti R, Almasio PL, Buscemi S, Famà F, Craxì A, Di Vita G. Inguinal hernioplasty improves the quality of life in patients with cirrhosis. Am J Surg. 2008;196:373-378. [PMID: 18639226 DOI: 10.1016/j.amjsurg.2008.02.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
191 Theodorakopoulos T, Kalafateli M, Kalambokis GN, Samonakis DN, Aggeletopoulou I, Tsolias C, Mantaka A, Tselekouni P, Vourli G, Assimakopoulos SF, Gogos C, Thomopoulos K, Milionis H, Triantos C. Natural history of grade 1 ascites in patients with liver cirrhosis. Ann Gastroenterol 2021;34:93-103. [PMID: 33414628 DOI: 10.20524/aog.2020.0553] [Reference Citation Analysis]
192 Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol 2009;21:370-5. [PMID: 20611006 DOI: 10.1097/MEG.0b013e328318ed19] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
193 Shahabeddin Parizi A, Vermeulen KM, Gomes-Neto AW, van der Bij W, Blokzijl H, Buskens E, Bakker SJ, Krabbe PF. Using a novel concept to measure outcomes in solid organ recipients provided promising results. J Clin Epidemiol 2021;139:96-106. [PMID: 34273526 DOI: 10.1016/j.jclinepi.2021.07.005] [Reference Citation Analysis]
194 Nakanishi H, Kurosaki M, Tsuchiya K, Nakakuki N, Takada H, Matsuda S, Gondo K, Asano Y, Hattori N, Tamaki N, Suzuki S, Yasui Y, Hosokawa T, Itakura J, Takahashi Y, Izumi N. L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2015;13:1540-3. [PMID: 25496816 DOI: 10.1016/j.cgh.2014.12.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
195 Tapper EB, Kanwal F, Asrani SK, Ho C, Ovchinsky N, Poterucha J, Flores A, Smith JE, Ankoma-Sey V, Luxon B, Volk ML. Patient-reported outcomes in cirrhosis: A scoping review of the literature. Hepatology 2018;67:2375-83. [PMID: 29272043 DOI: 10.1002/hep.29756] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
196 Frith J, Newton JL. Autonomic dysfunction in chronic liver disease. Liver Int. 2009;29:483-489. [PMID: 19323779 DOI: 10.1111/j.1478-3231.2009.01985.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
197 Hartshorn KL, Karnad AB, Tauber AI. Influenza A virus and the neutrophil: a model of natural immunity. J Leukoc Biol 1990;47:176-86. [PMID: 2406357 DOI: 10.1002/jlb.47.2.176] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
198 Rogal SS, Winger D, Bielefeldt K, Rollman BL, Szigethy E. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int. 2013;33:1497-1503. [PMID: 23758842 DOI: 10.1111/liv.12215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
199 Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol. 2007;4:677-685. [PMID: 18043677 DOI: 10.1038/ncpgasthep0999] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
200 Dunn SH, Rogal SS, Maier MM, Chartier M, Morgan TR, Beste LA. Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration. Dig Dis Sci 2019;64:3471-9. [PMID: 31432344 DOI: 10.1007/s10620-019-05785-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
201 McLean KA, Drake TM, Sgrò A, Camilleri-Brennan J, Knight SR, Ots R, Adair A, Wigmore SJ, Harrison EM. The effect of liver transplantation on patient-centred outcomes: a propensity-score matched analysis. Transpl Int 2019;32:808-19. [PMID: 30793373 DOI: 10.1111/tri.13416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
202 Pezzilli R, Morselli Labate AM, Ceciliato R, Frulloni L, Cavestro GM, Comparato G, Ferri B, Corinaldesi R, Gullo L. Quality of life in patients with chronic pancreatitis. Dig Liver Dis. 2005;37:181-189. [PMID: 15888283 DOI: 10.1016/j.dld.2004.10.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
203 Marchesini G, Bianchi G. Disease and comorbidity—effects on quality of life. Nat Rev Gastroenterol Hepatol 2009;6:504-6. [DOI: 10.1038/nrgastro.2009.142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
204 Eskes ECB, Sjouke B, Vaz FM, Goorden SMI, van Kuilenburg ABP, Aerts JMFG, Hollak CEM. Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers. Mol Genet Metab 2020;130:16-26. [PMID: 32088119 DOI: 10.1016/j.ymgme.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
205 Kalaitzakis E, Björnsson E. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life. Hepatology. 2007;46:949-50; author reply 951. [PMID: 17879365 DOI: 10.1002/hep.21760] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
206 Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010;22:221-227. [PMID: 19794311 DOI: 10.1097/meg.0b013e3283319975] [Cited by in Crossref: 95] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
207 Kalaitzakis E, Josefsson A, Björnsson E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol. 2008;8:46. [PMID: 18922174 DOI: 10.1186/1471-230x-8-46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
208 Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006;35:201-19. [PMID: 16530121 DOI: 10.1016/j.gtc.2005.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
209 Gorospe FF, Istanboulian L, Puts M, Wong D, Lee E, Dale CM. A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease. Can J Pain 2020;4:210-24. [PMID: 33987500 DOI: 10.1080/24740527.2020.1785855] [Reference Citation Analysis]
210 Escorsell À, Bañares R, García-pagán JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial. Hepatology 2002;35:385-92. [DOI: 10.1053/jhep.2002.30418] [Cited by in Crossref: 162] [Cited by in F6Publishing: 117] [Article Influence: 9.0] [Reference Citation Analysis]
211 Chiu E, Marr K, Taylor L, Lam L, Stapleton M, Tandon P, Raman M. Malnutrition Impacts Health-Related Quality of Life in Cirrhosis: A Cross-Sectional Study. Nutr Clin Pract 2020;35:119-25. [PMID: 30806489 DOI: 10.1002/ncp.10265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 邓文君, 张海蓉, 李红樱, 石围. 肝硬化患者生存质量的影响因素. 世界华人消化杂志 2015; 23(17): 2729-2735 [DOI: 10.11569/wcjd.v23.i17.2729] [Reference Citation Analysis]
213 Enezi AAl, Al-Jahdali F, Ahmed AE, Shirbini N, Harbi AAl, Salim B, Ali YZ, Abdulrahman A, Khan M, Khaleid A, Hamdan AJ. Symptoms of Daytime Sleepiness and Sleep Apnea in Liver Cirrhosis Patients. Ann Hepatol 2017;16:591-8. [PMID: 28611264 DOI: 10.5604/01.3001.0010.0304] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
214 Jafari SA, Rezaeian A, Namjou Z, Ghayour-Mobarhan M, Ghaneifar Z. Evaluation of nutritional adjustment program on quality of life in children with chronic liver disease. J Educ Health Promot 2021;10:141. [PMID: 34222516 DOI: 10.4103/jehp.jehp_855_20] [Reference Citation Analysis]
215 Walcott-Sapp S, Billingsley KG. Preoperative optimization for major hepatic resection. Langenbecks Arch Surg 2018;403:23-35. [PMID: 29150719 DOI: 10.1007/s00423-017-1638-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
216 David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:1904-1912. [PMID: 19434741 DOI: 10.1002/hep.22868] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
217 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
218 Córdoba J, Flavià M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231-238. [PMID: 12873820 DOI: 10.1016/s0168-8278(03)00189-2] [Cited by in Crossref: 146] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
219 Jin XY, Khan TM. Quality of life among patients suffering from cholestatic liver disease-induced pruritus: A systematic review. J Formos Med Assoc. 2016;115:689-702. [PMID: 27431691 DOI: 10.1016/j.jfma.2016.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
220 Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080-1090. [PMID: 20822500 DOI: 10.1111/j.1365-2036.2010.04448.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
221 Gutteling JJ, de Man RA, van der Plas SM, Schalm SW, Busschbach JJ, Darlington AS. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther 2006;23:1629-35. [PMID: 16696813 DOI: 10.1111/j.1365-2036.2006.02934.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
222 Yamanaka-Okumura H, Nakamura T, Miyake H, Takeuchi H, Katayama T, Morine Y, Imura S, Shimada M, Takeda E. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol Res. 2010;40:470-476. [PMID: 20412329 DOI: 10.1111/j.1872-034x.2010.00637.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
223 Bianchi G, Marzocchi R, Agostini F, Marchesini G. Update on branched-chain amino acid supplementation in liver diseases: . Current Opinion in Gastroenterology 2005;21:197-200. [DOI: 10.1097/01.mog.0000153353.45738.bf] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
224 Kalaitzakis E, Josefsson A, Castedal M, Henfridsson P, Bengtsson M, Hugosson I, Andersson B, Björnsson E. Factors related to fatigue in patients with cirrhosis before and after liver transplantation. Clin Gastroenterol Hepatol. 2012;10:174-81, 181.e1. [PMID: 21839709 DOI: 10.1016/j.cgh.2011.07.029] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
225 Vidot H, Carey S, Allman-Farinelli M, Shackel N. Systematic review: the treatment of muscle cramps in patients with cirrhosis. Aliment Pharmacol Ther. 2014;40:221-232. [PMID: 24942957 DOI: 10.1111/apt.12827] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
226 Barnes A, Woodman RJ, Kleinig P, Briffa M, To T, Wigg AJ. Early palliative care referral in patients with end stage liver disease is associated with reduced resource utilisation. J Gastroenterol Hepatol 2019. [PMID: 31613397 DOI: 10.1111/jgh.14877] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
227 Forlani G, Zannoni C, Tarrini G, Melchionda N, Marchesini G. An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetes. J Endocrinol Invest 2006;29:405-12. [DOI: 10.1007/bf03344123] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
228 Ray I, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol. 2010;29:187-195. [PMID: 20740340 DOI: 10.1007/s12664-010-0036-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
229 Montagnese S, Bajaj JS. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs 2019;79:11-6. [PMID: 30706419 DOI: 10.1007/s40265-018-1019-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
230 Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38:399-411. [PMID: 28921801 DOI: 10.1111/liv.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
231 Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes 2012;5:446. [PMID: 22905795 DOI: 10.1186/1756-0500-5-446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
232 Tanikella R, Kawut SM, Brown RS Jr, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB. Health-related quality of life and survival in liver transplant candidates. Liver Transpl 2010;16:238-45. [PMID: 20104497 DOI: 10.1002/lt.21984] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
233 Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry MP. Is Model for End-Stage Liver Disease Score Associated with Quality of Life after Liver Transplantation? Prog Transpl 2011;21:207-14. [DOI: 10.1177/152692481102100305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
234 Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1250-1257. [PMID: 21971378 DOI: 10.1097/meg.0b013e32834d1938] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
235 Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C, Khanthavit A. Factors influencing health-related quality of life in chronic liver disease. World J Gastroenterol 2006; 12(48): 7786-7791 [PMID: 17203521 DOI: 10.3748/wjg.v12.i48.7786] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
236 Polis S, Fernandez R. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. JBI Database System Rev Implement Rep 2015;13:39-51. [PMID: 26447006 DOI: 10.11124/jbisrir-2015-1987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
237 Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003;38:1219-26. [PMID: 14578860 DOI: 10.1053/jhep.2003.50477] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
238 Kato A, Tanaka H, Kawaguchi T, Kanazawa H, Iwasa M, Sakaida I, Moriwaki H, Murawaki Y, Suzuki K, Okita K. Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study. Hepatol Res. 2013;43:452-458. [PMID: 22994429 DOI: 10.1111/j.1872-034x.2012.01092.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
239 Abd-Elsalam S, El-Kalla F, Ali LA, Mosaad S, Alkhalawany W, Elemary B, Badawi R, Elzeftawy A, Hanafy A, Elfert A. Pilot study of orphenadrine as a novel treatment for muscle cramps in patients with liver cirrhosis. United European Gastroenterol J 2018;6:422-7. [PMID: 29774156 DOI: 10.1177/2050640617731261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
240 Bajaj JS, Hafeezullah M, Zadvornova Y, Martin E, Schubert CM, Gibson DP, Hoffmann RG, Sanyal AJ, Heuman DM, Hammeke TA. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol. 2009;104:898-905. [PMID: 19277025 DOI: 10.1038/ajg.2009.7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
241 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. 2017;7:340-357. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 13.5] [Reference Citation Analysis]
242 Goel A, Jat SL, Sasi A, Paliwal VK, Aggarwal R. Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India. Indian J Gastroenterol. 2016;35:216-221. [PMID: 27225798 DOI: 10.1007/s12664-016-0668-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
243 Prakash RK, Mullen KD. Is poor quality of life always present with minimal hepatic encephalopathy? Liver Int 2011;31:908-10. [PMID: 21733080 DOI: 10.1111/j.1478-3231.2011.02532.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
244 Fagiuoli S, Caporaso N, Morisco F, Buelli F, Gualberti G, Saragaglia V, Chessa L, Corti G, Maida I, Mastroianni CM, Pirisi M, Russo FP, Farina F, Giannitrapani L, Toniutto P, Tarquini P, Tundo P, Vecchiet J, Vinci M, Taliani G; HepaDisk Study Group. HepaDisk - A new quality of life questionnaire for HCV patients. Dig Liver Dis 2019;51:1008-15. [PMID: 30661988 DOI: 10.1016/j.dld.2018.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
245 Shukla R, Kramer J, Cao Y, Ying J, Tansel A, Walder A, Advani S, El-serag HB, Kanwal F. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. American Journal of Gastroenterology 2016;111:1778-87. [DOI: 10.1038/ajg.2016.440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
246 Fricker ZP, Serper M. Current Knowledge, Barriers to Implementation, and Future Directions in Palliative Care for End‐Stage Liver Disease. Liver Transpl 2019;25:787-96. [DOI: 10.1002/lt.25434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
247 Kotarska K, Wunsch E, Kempińska-Podhorodecka A, Raszeja-Wyszomirska J, Bogdanos DP, Wójcicki M, Milkiewicz P. Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study. J Immunol Res 2014;2014:738297. [PMID: 24741621 DOI: 10.1155/2014/738297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
248 Berzigotti A. Advances and challenges in cirrhosis and portal hypertension. BMC Med. 2017;15:200. [PMID: 29121925 DOI: 10.1186/s12916-017-0966-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
249 Kawaratani H, Moriya K, Namisaki T, Shimozato N, Kaji K, Takaya H, Fujinaga Y, Sawada Y, Sato S, Saikawa S, Kubo T, Akahane T, Fukui H, Yoshiji H. Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites. Exp Ther Med 2021;21:30. [PMID: 33262816 DOI: 10.3892/etm.2020.9462] [Reference Citation Analysis]
250 Premkumar M, Devurgowda D, Vyas T, Shasthry SM, Khumuckham JS, Goyal R, Thomas SS, Kumar G. Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis. J Clin Exp Hepatol 2019;9:324-33. [PMID: 31360025 DOI: 10.1016/j.jceh.2018.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
251 Yan L, Xie F, Lu J, Ni Q, Shi C, Tang C, Yang J. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65. [PMID: 26054761 DOI: 10.1186/s12876-015-0297-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
252 Holden JH, Shamseddeen H, Johnson AW, Byriel B, Subramoney K, Cheng YW, Saito A, Ghabril M, Chalasani N, Sachs GA, Orman ES. Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important? J Palliat Med 2020;23:1066-75. [PMID: 32091954 DOI: 10.1089/jpm.2019.0501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
253 Onishi Y, Wakita T, Fukuhara S, Noguchi Y, Okada M, Sakaida I, Sasaki Y, Kobayashi K. Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7. Clin Transl Gastroenterol 2014;5:e48. [PMID: 24500340 DOI: 10.1038/ctg.2013.20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
254 Inghilesi AL, Gallori D, Antonuzzo L, Forte P, Tomcikova D, Arena U, Colagrande S, Pradella S, Fani B, Gianni E, Boni L, Laffi G, Costanzo FD, Marra F. Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2014; 20(3): 786-794 [PMID: 24574751 DOI: 10.3748/wjg.v20.i3.786] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
255 Suzuki H, Sezaki H, Suzuki F, Kasuya K, Sano T, Fujiyama S, Kawamura Y, Hosaka T, Akuta N, Saitoh S, Kobayashi M, Arase Y, Ikeda K, Suzuki Y, Kumada H. Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy. Hepatol Res 2019;49:1406-13. [DOI: 10.1111/hepr.13415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
256 Younossi ZM, Golabi P, Henry L. A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases. Journal of Clinical Gastroenterology 2019;53:331-41. [DOI: 10.1097/mcg.0000000000001179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
257 Younossi Z, Henry L. Overall health-related quality of life in patients with end-stage liver disease. Clin Liver Dis (Hoboken) 2015;6:9-14. [PMID: 31040976 DOI: 10.1002/cld.480] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
258 Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19:122-134. [PMID: 23172830 DOI: 10.1002/lt.23574] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
259 Younossi Z, Henry L. Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens. Aliment Pharmacol Ther. 2015;41:497-520. [PMID: 25616122 DOI: 10.1111/apt.13090] [Cited by in Crossref: 124] [Cited by in F6Publishing: 124] [Article Influence: 20.7] [Reference Citation Analysis]
260 Ghabril M, Jackson M, Gotur R, Weber R, Orman E, Vuppalanchi R, Chalasani N. Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life. Clin Gastroenterol Hepatol 2017;15:1271-1278.e6. [PMID: 28167158 DOI: 10.1016/j.cgh.2017.01.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
261 Kappus MR, Leszczyszyn DJ, Moses L, Raman S, Heuman DM, Bajaj JS. Effect of obstructive sleep apnea on the sleep architecture in cirrhosis. J Clin Sleep Med 2013;9:247-51. [PMID: 23494006 DOI: 10.5664/jcsm.2488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
262 Perng CL, Shen CC, Hu LY, Yeh CM, Chen MH, Tsai CF, Chiang HL, Hung YP, Su VY, Hu YW, Su TP, Chen PM, Hung JH, Liu CJ, Huang MW. Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study. PLoS One 2014;9:e88721. [PMID: 24533141 DOI: 10.1371/journal.pone.0088721] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
263 Erceg S, Monfort P, Cauli O, Montoliu C, Llansola M, Piedrafita B, Felipo V. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications. Neurochem Int 2006;48:441-6. [PMID: 16497413 DOI: 10.1016/j.neuint.2005.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
264 Toda K, Miwa Y, Kuriyama S, Fukushima H, Shiraki M, Murakami N, Shimazaki M, Ito Y, Nakamura T, Sugihara J, Tomita E, Nagata C, Suzuki K, Moriwaki H. Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition. J Gastroenterol 2005;40:894-900. [DOI: 10.1007/s00535-005-1634-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
265 Campbell MS, Brensinger CM, Sanyal AJ, Gennings C, Wong F, Kowdley KV, McCashland T, Reddy KR. Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy. Hepatology. 2005;42:635-640. [PMID: 16108073 DOI: 10.1002/hep.20840] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
266 Bianchi G, Giovagnoli M, Sasdelli AS, Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012;16:159-70. [PMID: 22321471 DOI: 10.1016/j.cld.2011.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
267 Naik AD, Arney J, Clark JA, Martin LA, Walling AM, Stevenson A, Smith D, Asch SM, Kanwal F. Integrated Model for Patient-Centered Advanced Liver Disease Care. Clinical Gastroenterology and Hepatology 2020;18:1015-24. [DOI: 10.1016/j.cgh.2019.07.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
268 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998: Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gast. Hepatology 2002;35:716-21. [DOI: 10.1053/jhep.2002.31250] [Cited by in Crossref: 1381] [Cited by in F6Publishing: 1202] [Article Influence: 76.7] [Reference Citation Analysis]
269 Labenz C, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. J Clin Gastroenterol 2019;53:e303-7. [PMID: 30439761 DOI: 10.1097/MCG.0000000000001149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
270 Solbach P, Höner Zu Siederdissen C, Taubert R, Ziegert S, Port K, Schneider A, Hueper K, Manns MP, Wedemeyer H, Jaeckel E. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis. Eur J Gastroenterol Hepatol 2017;29:539-46. [PMID: 28350743 DOI: 10.1097/MEG.0000000000000837] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
271 Iwasa M, Karino Y, Kawaguchi T, Nakanishi H, Miyaaki H, Shiraki M, Nakajima T, Sawada Y, Yoshiji H, Okita K, Koike K. Relationship of muscle cramps to quality of life and sleep disturbance in patients with chronic liver diseases: A nationwide study. Liver Int 2018;38:2309-16. [DOI: 10.1111/liv.13745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
272 Doria C. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transplantation 2003;9:437-43. [DOI: 10.1053/jlts.2003.50055] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
273 Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol. 2004;2:157-163. [PMID: 15017621 DOI: 10.1016/s1542-3565(03)00315-x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
274 Montagnese S, Middleton B, Skene DJ, Morgan MY. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver International 2009;29:1372-82. [DOI: 10.1111/j.1478-3231.2009.02089.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
275 Jara M, Bednarsch J, Malinowski M, Lüttgert K, Orr J, Puhl G, Seehofer D, Neuhaus P, Stockmann M. Predictors of quality of life in patients evaluated for liver transplantation. Clin Transplant 2014;28:1331-8. [PMID: 25053350 DOI: 10.1111/ctr.12426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
276 Aguiar I, Lins-Kusterer L, Lins LS, Paraná R, Bastos J, Carvalho FM. Quality of life, work ability and oral health among patients with chronic liver diseases. Med Oral Patol Oral Cir Bucal 2019;24:e392-7. [PMID: 31041917 DOI: 10.4317/medoral.22918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
277 Larson AM. Palliative Care for Patients with End-Stage Liver Disease. Curr Gastroenterol Rep 2015;17. [DOI: 10.1007/s11894-015-0440-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
278 Zhou Y, Chen S, Jiang L, Guo C, Shen Z, Huang P, Wang J. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2009;24:408-15. [DOI: 10.1111/j.1440-1746.2008.05678.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
279 Kimbell B, Boyd K, Kendall M, Iredale J, Murray SA. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open 2015;5:e009241. [PMID: 26586325 DOI: 10.1136/bmjopen-2015-009241] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
280 Wehler M, Nichterlein R, Fischer B, Farnbacher M, Reulbach U, Hahn EG, Schneider T. Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol. 2004;99:138-146. [PMID: 14687155 DOI: 10.1111/j.1572-0241.2004.04005.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
281 Grønkjær LL, Andersen NG, Hansen LB, Sehstedt TH, Svensson NT, Sømod IE, Norlyk A, Bager P. Different views on hepatic encephalopathy: patients, relatives and nurses. Gastrointestinal Nursing 2016;14:S24-31. [DOI: 10.12968/gasn.2016.14.sup10.s24] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
282 Huang HC, Chen MY, Hsieh LW, Chiu HY, Miao NF, Wu CS, Lin KC. Validation of a Symptoms Distress Scale in a Cirrhotic Population Using Item Response Theory. Nurs Res 2018;67:359-68. [PMID: 30160660 DOI: 10.1097/NNR.0000000000000296] [Reference Citation Analysis]
283 Šumskienė J, Kupčinskas L, Šumskas L. Health-related quality of life measurement in chronic liver disease patients. Medicina (Kaunas) 2015;51:201-8. [PMID: 26424183 DOI: 10.1016/j.medici.2015.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
284 Macdonald S, Jepsen P, Alrubaiy L, Watson H, Vilstrup H, Jalan R. Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Aliment Pharmacol Ther 2019;49:321-30. [PMID: 30585338 DOI: 10.1111/apt.15084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
285 Kanwal F. Patient-reported outcomes of cirrhosis. Clin Gastroenterol Hepatol 2013;11:1043-5. [PMID: 23867130 DOI: 10.1016/j.cgh.2013.07.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
286 Moscucci F, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, Riggio O. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int 2011;31:1505-10. [PMID: 22093325 DOI: 10.1111/j.1478-3231.2011.02598.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
287 Gazineo D, Godino L, Bui V, El Mouttaqi L, Franciosi E, Natalino A, Ceci G, Ambrosi E. Health-related quality of life in outpatients with chronic liver disease: a cross-sectional study. BMC Gastroenterol 2021;21:318. [PMID: 34364363 DOI: 10.1186/s12876-021-01890-7] [Reference Citation Analysis]
288 Ismond KP, Eslamparast T, Farhat K, Stickland M, Spence JC, Bailey RJ, Abraldes JG, Spiers JA, Tandon P. Assessing Patient Proficiency with Internet-Connected Technology and Their Preferences for E-Health in Cirrhosis. J Med Syst 2021;45:72. [PMID: 34091771 DOI: 10.1007/s10916-021-01746-3] [Reference Citation Analysis]
289 Rabiee A, Ximenes RO, Nikayin S, Hickner A, Juthani P, Rosen RH, Garcia-Tsao G. Factors associated with health-related quality of life in patients with cirrhosis: a systematic review. Liver Int 2021;41:6-15. [PMID: 32998172 DOI: 10.1111/liv.14680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
290 Tsai L, Lin C, Chiang S, Chen C, Lan S, See L. Symptoms and Distress Among Patients With Liver Cirrhosis but Without Hepatocellular Carcinoma in Taiwan. Gastroenterology Nursing 2014;37:49-59. [DOI: 10.1097/sga.0000000000000020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
291 Dehghan Nayeri N, Asadi Noghabi AA, Molaee S. The Effect of Telephone Consultation on the Quality of Life of Patients Receiving Interferon Therapy: A Quasi-experimental Study. Telemedicine and e-Health 2012;18:459-63. [DOI: 10.1089/tmj.2011.0164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 Román E, Córdoba J, Torrens M, Guarner C, Soriano G. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. Eur J Gastroenterol Hepatol 2013;25:77-84. [PMID: 22954704 DOI: 10.1097/MEG.0b013e3283589f49] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
293 Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13(29): 3996-4001 [PMID: 17663517 DOI: 10.3748/wjg.v13.i29.3996] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
294 Schenk P, Warszawska J, Fuhrmann V, König F, Madl C, Ratheiser K. Health-related quality of life of long-term survivors of intensive care: changes after intensive care treatment. Experience of an Austrian intensive care unit. Wien Klin Wochenschr 2012;124:624-32. [PMID: 22875391 DOI: 10.1007/s00508-012-0224-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793-799. [PMID: 19306949 DOI: 10.1016/j.cgh.2009.03.013] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 7.3] [Reference Citation Analysis]
296 Kelly SG, Campbell TC, Hillman L, Said A, Lucey MR, Agarwal PD. The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review. Annals of Hepatology 2017;16:395-401. [DOI: 10.5604/01.3001.0009.8594] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
297 Wu J, Xiao J, Li T, Li X, Sun H, Chow EP, Lu Y, Tian T, Li X, Wang Q, Zhuang X, Zhang L. A cross-sectional survey on the health status and the health-related quality of life of the elderly after flood disaster in Bazhong city, Sichuan, China. BMC Public Health 2015;15:163. [PMID: 25884807 DOI: 10.1186/s12889-015-1402-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]